Table 1—

Baseline characteristics for all patients receiving treatment

Insulin detemirNPH insulin
n301146
Age (years)38.9 ± 13.341.8 ± 14.2
Sex
 M162 (53.8)74 (50.7)
 F139 (46.2)72 (49.3)
Weight (kg)71.5 ± 11.971.2 ± 11.5
BMI (kg/m2)24.5 ± 3.224.6 ± 3.4
Diabetes duration (years)17.1 ± 9.917.4 ± 11.0
FPG (mmol/l)11.6 ± 5.2111.6 ± 5.27
HbA1c (%)8.18 ± 1.148.11 ± 1.12
Total daily insulin dose (units)*
 Basal27.4 ± 12.525.2 ± 13.7
 Bolus30.9 ± 15.529.6 ± 15.8
  • Data are means ± SD or n (%).

  • *

    * Does not include patients using premix insulin at study start: insulin detemir group, 27 IU/U (n = 1); NPH insulin group, 40 IU/U (n = 1).